Real Review,have been shown to block invasion of basement membranes by tumor cells

The cgyigsr peptide, more commonly known as YIGSR peptide, is a fascinating and extensively studied laminin peptide. Derived from the beta-1 chain of laminin, this laminin pentapeptide (Tyr-Ile-Gly-Ser-Arg) has demonstrated a diverse range of biological activities, making it a subject of significant interest in various research fields, from cancer biology to tissue engineering and wound healing. Its ability to interact with specific cellular receptors and influence fundamental processes like cell adhesion, migration, and differentiation underscores its potential as a therapeutic agent and a valuable research tool.

One of the most well-documented functions of the YIGSR sequence is its role in promoting cell adhesion and influencing cell behavior. This laminin-derived peptide is known to bind to the 67 kDa laminin binding protein (LBP), a crucial receptor found on the surface of numerous cell types, including endothelial cells. This interaction facilitates the attachment, migration, and organization of cells, which are fundamental processes during embryonic development and tissue repair. The YIGSR peptide's involvement in mediating cell attachment is critical for the formation of tissues and the maintenance of their structural integrity.

Beyond its general role in cell adhesion, research has highlighted the YIGSR peptide's specific impact on collagen synthesis. Studies have clearly revealed that the YIGSR peptide plays a novel function in stimulating collagen type 1 synthesis in dermal fibroblasts. This is particularly relevant for wound healing and anti-aging applications, as collagen is a primary structural protein in the skin, essential for its strength and elasticity. By increasing collagen type 1 synthesis, the YIGSR peptide can contribute to enhanced tissue regeneration and repair.

The influence of the YIGSR peptide extends to the realm of immunology, particularly in modulating macrophage inflammatory state. Research indicates that YIGSR can be used as a tool to modulate macrophage phenotypes, with its effects potentially varying depending on the concentration of peptide used. Some studies suggest that YIGSR acts as a macrophage manipulating peptide, enhancing inflammation and inflammatory chemokines at lower concentrations. This ability to influence immune cell responses opens avenues for exploring its use in managing inflammatory conditions.

In the context of cancer research, the YIGSR sequence has demonstrated a significant inhibitory effect on tumor growth and metastasis. The YIGSR peptide has been shown to block invasion of basement membranes by tumor cells, a critical step in the metastatic cascade. More specifically, studies have found that peptide 11 and its terminal pentapeptide YIGSR inhibit tumor cell invasion. Furthermore, the YIGSR sequence on laminin may regulate tumor growth due to its effects on both angiogenesis and direct tumor cell interactions. In some instances, the YIGSR peptide is associated with angiogenesis inhibition, a process vital for tumor survival and expansion. The ability of YIGSR-NH2 to inhibit the invasiveness of melanoma cells in vitro further solidifies its anti-cancer potential.

The significance of the YIGSR sequence as a cell-adhesive motif within laminin is further emphasized by its use in advanced biomaterials. For example, VitroGel YIGSR High Concentration is a tunable, xeno-free hydrogel system modified with this laminin-derived functional peptide. Such hydrogels are valuable for 3D cell culture, providing a more physiologically relevant environment for studying cell behavior and drug screening. The YIGSR segment has also been shown to promote cellular uptake through interaction with laminin receptors, leading to improved gene transfection efficiency.

The YIGSR peptide is available in various forms for research purposes, including Laminin Peptide YIGSR-NH2, which is a synthetic peptide with a molecular weight of approximately 593.67-593.68 Da and a purity of ≥98%. This form is soluble in water and typically stored at -20°C. Researchers can also find YIGSR amide / Laminin Pentapeptide amide for their studies. The sequence Tyr-Ile-Gly-Ser-Arg (T7154) represents the YIGSR pentapeptide, occurring from amino acids 929-933 in the laminin protein, and is recognized as a major receptor binding site.

Emerging research also points to the therapeutic potential of the YIGSR peptide in conditions like lymphedema. YIGSR treatment protected lymphedema impairment in epidermis and dermis, inhibited the expansion of intercellular spaces, and enhanced certain tissue structures. The YIGSR peptide is also being explored for its ability to enhance epidermal development.

In summary, the cgyigsr peptide, or YIGSR peptide, is a remarkable laminin peptide with a broad spectrum of biological activities. Its ability to promote cell adhesion, stimulate collagen type 1 synthesis, modulate immune responses, inhibit tumor growth and metastasis, and enhance tissue